Editorials

Molecular assessment and the current limits of post-transplant prognostication for chronic myelomonocytic leukemia

Division of Hematologic Malignancies, Dana-Farber Cancer Institute 450 Brookline Ave., Boston MA 02215
Division of Hematologic Malignancies, Dana-Farber Cancer Institute 450 Brookline Ave., Boston MA 02215
Haematologica Early view Apr 21, 2022 https://doi.org/10.3324/haematol.2022.280960